David M. Peng

1.8k total citations
78 papers, 748 citations indexed

About

David M. Peng is a scholar working on Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David M. Peng has authored 78 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 48 papers in Biomedical Engineering and 27 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David M. Peng's work include Mechanical Circulatory Support Devices (48 papers), Cardiac Structural Anomalies and Repair (38 papers) and Transplantation: Methods and Outcomes (21 papers). David M. Peng is often cited by papers focused on Mechanical Circulatory Support Devices (48 papers), Cardiac Structural Anomalies and Repair (38 papers) and Transplantation: Methods and Outcomes (21 papers). David M. Peng collaborates with scholars based in United States, Canada and Germany. David M. Peng's co-authors include Angela Lorts, David L.S. Morales, Ryan S. Cantor, Katsuhide Maeda, James K. Kirklin, David N. Rosenthal, Devin Koehl, Jennifer Conway, Christina VanderPluym and Jeffrey P. Jacobs and has published in prestigious journals such as Circulation, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

David M. Peng

62 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Peng United States 15 568 521 246 205 167 78 748
Aamir Jeewa Canada 17 626 1.1× 557 1.1× 244 1.0× 337 1.6× 205 1.2× 104 922
Elizabeth Pruitt United States 15 482 0.8× 327 0.6× 174 0.7× 151 0.7× 60 0.4× 30 622
Hans Lidén Sweden 13 601 1.1× 344 0.7× 273 1.1× 313 1.5× 83 0.5× 32 850
Charles F. Evans United States 14 371 0.7× 300 0.6× 110 0.4× 201 1.0× 126 0.8× 25 634
Deirdre J. Epstein United States 11 423 0.7× 370 0.7× 157 0.6× 95 0.5× 109 0.7× 17 512
Holger Buchholz Canada 14 446 0.8× 487 0.9× 201 0.8× 164 0.8× 186 1.1× 49 601
Ivar Risnes Norway 14 424 0.7× 251 0.5× 69 0.3× 127 0.6× 142 0.9× 25 624
Mirela Scherer Germany 16 354 0.6× 266 0.5× 97 0.4× 222 1.1× 170 1.0× 41 592
Pennington Dg United States 16 480 0.8× 434 0.8× 72 0.3× 158 0.8× 142 0.9× 33 569
Herbert Hangler Austria 15 404 0.7× 121 0.2× 186 0.8× 370 1.8× 59 0.4× 42 636

Countries citing papers authored by David M. Peng

Since Specialization
Citations

This map shows the geographic impact of David M. Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Peng more than expected).

Fields of papers citing papers by David M. Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Peng. The network helps show where David M. Peng may publish in the future.

Co-authorship network of co-authors of David M. Peng

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Peng. A scholar is included among the top collaborators of David M. Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Peng. David M. Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowery, Ray, et al.. (2025). Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease. Pediatric Cardiology. 47(4). 1581–1590.
2.
Griffiths, Eric R., Shahnawaz Amdani, Ryan R. Davies, et al.. (2025). Eighth Annual Society of Thoracic Surgeons Pedimacs Report. The Annals of Thoracic Surgery. 119(3). 513–522. 1 indexed citations
3.
4.
Cusick, Matthew F., et al.. (2025). Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant. The Journal of Heart and Lung Transplantation. 44(4). S262–S262.
5.
Lorts, Angela, David N. Rosenthal, Iki Adachi, et al.. (2024). Predicting Stroke for Pediatric Patients Supported With Ventricular Assist Devices: A Pedimacs Report. The Annals of Thoracic Surgery. 118(4). 889–897. 2 indexed citations
6.
Lowery, Ray, et al.. (2024). Changes in nutritional status and the development of obesity and metabolic syndrome following pediatric heart transplantation. Pediatric Transplantation. 28(4). e14782–e14782. 2 indexed citations
7.
George, Roshan, Amy G. Feldman, Angela Lorts, et al.. (2024). Pediatric Learning Health Networks in Solid Organ Transplantation—Engaging all Stakeholders to Achieve Health for Children Who Require Transplantation. Pediatric Transplantation. 28(7). e14862–e14862.
8.
Deshpande, Shriprasad R., Robert J. Gajarski, Bibhuti B. Das, et al.. (2024). Critical care therapies pre- and post-heart transplant and their impact: Analysis from the Pediatric Cardiac Critical Care Consortium. The Journal of Heart and Lung Transplantation. 43(9). 1434–1449.
9.
Butts, Ryan J., James K. Kirklin, Kurt R. Schumacher, et al.. (2024). Waitlist Outcomes for Pediatric Heart Transplantation in the Current Era: An Analysis of the Pediatric Heart Transplant Society Database. Circulation. 150(5). 362–373. 4 indexed citations
10.
11.
Peng, David M., Ryan R. Davies, Kathleen E. Simpson, et al.. (2023). Seventh Annual Society of Thoracic Surgeons Pedimacs Report. The Annals of Thoracic Surgery. 117(4). 690–703. 14 indexed citations
12.
Lubert, Adam M., Ari Cedars, Christopher S. Almond, et al.. (2023). Considerations for Advanced Heart Failure Consultation in Individuals With Fontan Circulation: Recommendations From ACTION. Circulation Heart Failure. 16(2). e010123–e010123. 21 indexed citations
13.
Lorts, Angela, David N. Rosenthal, Iki Adachi, et al.. (2023). Survival in Pediatric Patients With Ventricular Assist Devices: A Special Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. The Annals of Thoracic Surgery. 116(5). 972–979. 3 indexed citations
14.
Peng, David M., et al.. (2023). (1102) Daratumumab for Chronic Antibody Mediated Rejection and Subsequent Successful Pediatric Heart-Kidney Retransplantation. The Journal of Heart and Lung Transplantation. 42(4). S474–S474.
15.
Peng, David M., Sunkyung Yu, Ray Lowery, et al.. (2022). Self‐reported quality of life in children with ventricular assist devices. Pediatric Transplantation. 26(4). e14237–e14237. 4 indexed citations
16.
Avanceña, Anton L.V., et al.. (2021). Cost‐effectiveness of implantable ventricular assist devices in older children with stable, inotrope‐dependent dilated cardiomyopathy. Pediatric Transplantation. 25(4). e13975–e13975. 1 indexed citations
17.
Yu, Sunkyung, et al.. (2021). Predictors and clinical significance of pericardial effusions after pediatric heart transplantation. Pediatric Transplantation. 26(1). e14153–e14153. 1 indexed citations
18.
Law, Sabrina, David L.S. Morales, Ming‐Sing Si, et al.. (2021). Right heart failure considerations in pediatric ventricular assist devices. Pediatric Transplantation. 25(3). e13990–e13990. 4 indexed citations
19.
Simpson, Kathleen E., James K. Kirklin, Ryan S. Cantor, et al.. (2019). Right heart failure with left ventricular assist device implantation in children: An analysis of the Pedimacs registry database. The Journal of Heart and Lung Transplantation. 39(3). 231–240. 17 indexed citations
20.
Peng, David M., Yulin Zhang, David N. Rosenthal, et al.. (2017). Impact of Heart Transplantation on the Functional Status of US Children With End-Stage Heart Failure. Circulation. 135(10). 939–950. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aamir Jeewa Breakdown of academic impact, for papers by Elizabeth Pruitt Breakdown of academic impact, for papers by Hans Lidén Breakdown of academic impact, for papers by Charles F. Evans Breakdown of academic impact, for papers by Deirdre J. Epstein Breakdown of academic impact, for papers by Holger Buchholz Breakdown of academic impact, for papers by Ivar Risnes Breakdown of academic impact, for papers by Mirela Scherer Breakdown of academic impact, for papers by Pennington Dg Breakdown of academic impact, for papers by Herbert Hangler
Rankless by CCL
2026